Ukrainian army holds military drills close to CrimeaMilitary & Defense April 27, 13:14
Press review: Planned Putin-Trump meeting and what may have prevented St. Petersburg blastPress Review April 27, 13:00
Saudi Arabia interested in purchasing Russian military hardwareMilitary & Defense April 27, 12:57
Damascus claims France involved in staging Khan Sheikhoun chemical attackWorld April 27, 12:23
Russian Investigative Committee denies Tu-154 crashed in Sochi due to overloadWorld April 27, 12:12
Russian intelligence chief doubts Trump’s election pledges to fight terrorism 'sincere'Russian Politics & Diplomacy April 27, 11:11
Foreign intelligence chief says current ideological standoff worse than Cold War eraRussian Politics & Diplomacy April 27, 11:10
Russian diplomat believes Western obsession with Assad leads to dead endRussian Politics & Diplomacy April 27, 10:30
Maria Sharapova wins first match after disqualificationSport April 27, 9:38
NOVOSIBIRSK, June 9. /TASS/. A new vaccine to protect against Ebola virus disease developed by Russia’s Vector research center of virology and biotechnology has successfully undergone the first stage of clinical tests, the acting director general of the research center told reporters on the sidelines of the international forum for technological development on Thursday.
"The first phase of clinical tests has been completed. It is now on approval at the Russian Ministry of Healthcare. We are waiting for a second phase," Valery Mikheyev said.
According to the World Health Organization (WHO), more than 11,300 people have died from Ebola in West Africa, primarily in Guinea, Sierra Leone and Liberia. More than 28,600 were infected. In January, Russia informed the WHO executive committee about its anti-Ebola vaccines.
The World Health Organization describes Ebola virus disease (formerly known as Ebola haemorrhagic fever) as "a severe, often fatal illness, with a case fatality rate of up to 90%." Until now, there has been no known cure or vaccine for the disease. The only treatment offered is "supportive intensive care." During an outbreak, those at higher risk of infection are health workers, family members and others in close contact with sick people and deceased patients.